Termination of the Vimpat Japan distribution and co-promotion agreement with UCB Biopharma
This covers the individual event in which the exclusive distribution and co-promotion agreement for Vimpat in Japan with UCB Biopharma Sprl ended on 30 August 2026 upon expiry of its 10-year term following the product's launch.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.